School-Based Vaccination Survey– November 2021

On Tuesday, November 2, the CDC approved the COVID-19 Pfizer vaccination for children ages 5 to 11 years. The approval means about 28 million children in the United States in this age group are eligible for the vaccine. NAESP would like to hear from its members to learn more about how the approval of the vaccine impacts schools and what additional supports might be necessary.

Question Title

* 1. In what state is your school located?

Question Title

* 2. My school is best described as:

Rural

Suburban

Urban

Question Title

* 3. School enrollment

<250

251-499

500-999

<1000

Question Title

* 4. Approximately, what percentage of students at your school are eligible for free or reduced-price lunch?

0-10%

11-20%

21-30%

31-40%

41-50%

51-60%

61-70%

71-80%

81-90%

91-100%

Question Title

* 5. Is your district planning to host school-based sites for COVID-⁠19 vaccinations for kids ages 5-11?

No

Yes

I'm not sure

Question Title

* 6. A vaccine for kids ages 5-11 has been authorized by the CDC and the FDA. How much do you agree or disagree with the following statement: I think it’s important for kids ages 5-11 to receive the vaccination.

Strongly agree

Agree

Neither agree nor disagree

Disagree

Strongly disagree

I'm not sure